Dr Richard Shaffer is a cancer specialist who uses radiotherapy and chemotherapy to treat brain tumours, skin cancer, prostate cancer, and bladder cancer.
He currently sees private patients in London and Guildford, and can treat patients in many other Genesis Care centres around the UK
He is currently clinical lead for development of radiotherapy for skin cancer and benign disease for GenesisCare UK.
Training and Appointment
Dr Shaffer previously worked as an NHS consultant from 2010-2019 at the Royal Surrey County Hospital in Guildford and also in Basingstoke. His brain tumour team won an award for their "excellent clinical performance". He has been Clinical Lead for Radiotherapy and Radiotherapy Development, led the development and implementation of the Stereotactic Radiosurgery programme in Surrey, and has been clinical lead for radiotherapy innovation for GenesisCare UK.
Dr Shaffer did his specialist training in London, and a Clinical Fellowship in Radiation Oncology in Vancouver, Canada. Whilst in Canada he completed a number of research projects in technical radiotherapy. Dr Shaffer has presented and been published widely in the oncology field.
Dr Shaffer previously chaired the IMRT-IGRT Radiotherapy Group and the Radiotherapy Technology Development Group, the Network Brain Tumour Working Group and was a member of the NCRI Brain Tumour Clinical Studies Group (2010 - 2015).
He was also a trustee of the Fountain Centre, a charity which provides information, support, counselling and complementary therapies for cancer patients, their carers and relatives at St Luke’s Cancer Centre at the Royal Surrey County Hospital.
He is an expert in the use of radiotherapy for the treatment of benign conditions and set up "The Dupuytren's Practice" to provide radiotherapy for patients with Dupuytren's and Ledderhose disease throughout the UK. He treats patients with heel pain with radiotherapy treatment for plantar fasciitis and Achilles tendonitis.
He co-wrote the recent Royal College of Radiologists report on the use of radiotherapy for benign disease. He has also given evidence to NICE on this subject.
There is more information about his practice at www.thedupuytrenspractice.com and www.heelpainpractice.com.